OPK Biotech  
OPK Biotech websites
Company Technology Research & Development Hemopure Oxyglobin Contact OPK Biotech
Technology & Products - Innovative Research in Oxygen Therapeutics
Home > Research & Development > Research Areas

Research Areas

Building upon the findings of numerous pre-clinical and clinical trials in several countries, OPK Biotech’s research strategy focuses on the development of Hemopure where it could help stabilize the patient and prevent tissue damage or organ dysfunction associated with oxygen deprivation in conditions, such as ischemia, anemia, and trauma.

Research Agreement with US Navy

OPK Biotech is collaborating with the U.S. Navy to test Hemopure in the pre-clinical, out-of hospital (e.g. at accident scenes, in ambulances or on the battlefield) treatment of hemorrhagic shock resulting from traumatic injury.

HBOCLAB.com
is a Resource Guide for individuals interested in the impact of OPK Biotech's Hemoglobin Based Oxygen Carriers (HBOCs) on laboratory assays. The information presented for Hemopure® also applies to Oxyglobin®.

Learn More
Hemopure
Hemopure® has been used to treat surgical anemia in South Africa since 2001.

Learn More

Oxyglobin
Oxyglobin® Solution

More than
200,000 units
have been
sold in the
United
States and
Europe.

Learn More